Y-Intercept (Hong Kong) Ltd - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
Y-Intercept (Hong Kong) Ltd ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$412,553
+34.4%
8,774
+9.0%
0.04%
-2.2%
Q4 2022$307,027
+0.0%
8,050
-13.1%
0.04%
-35.7%
Q1 2022$307,000
-60.9%
9,265
+4.6%
0.07%
-78.9%
Q4 2020$785,0008,8550.33%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 409,000$17,399,0004.82%
Palo Alto Investors LP 781,730$33,255,0002.12%
DAFNA Capital Management LLC 180,306$7,670,0001.93%
Boxer Capital, LLC 1,094,000$46,539,0001.81%
Deep Track Capital, LP 500,000$21,270,0001.50%
Bellevue Group AG 3,228,004$137,319,0001.42%
EcoR1 Capital, LLC 940,636$40,015,0001.28%
Deep Track Capital, LP 400,000$17,016,0001.20%
Artal Group S.A. 1,000,000$42,540,0001.15%
SECTOR GAMMA AS 98,904$4,207,0000.99%
View complete list of SAGE THERAPEUTICS INC shareholders